Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD‑induced obese mice

Li,Min; Sharma,Antara; Yin,Chunyan; Tan,Xinrui; Xiao,Yanfeng

doi:10.3892/mmr.2017.6637

Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD‑induced obese mice

Authors:
- Min Li
- Antara Sharma
- Chunyan Yin
- Xinrui Tan
- Yanfeng Xiao
View Affiliations

Affiliations: Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China, Pediatrics Department, 2nd Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China
Published online on: May 26, 2017 https://doi.org/10.3892/mmr.2017.6637
Pages: 680-686
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the effect of metformin on the induction of autophagy in the liver and adipose tissues of a mouse model of obesity. C57BL/6J mice were fed a high‑fat diet (HFD) for 12 weeks to induce obesity‑associated hepatic steatosis, and treated with metformin (150 mg/kg/d) by intraperitoneal injection for the final 4 weeks of HFD feeding. Body weight was recorded weekly, and the food intake of the mice was recorded daily during the treatment period. Liver and adipose tissues were harvested for histological and molecular analyses. The results revealed that metformin significantly reduced body weight without altering food intake in the HFD mice, particularly in the epididymal white adipose tissue (eWAT). Metformin treatment ameliorated HFD‑induced hepatic steatosis and serum levels of triglycerides, which was consistent with a marked increase in the expression levels of microtubule‑associated protein 1 light chain 3 (LC3) and AMP‑activated protein kinase (AMPK) in the liver following metformin treatment. However, metformin suppressed the expression of LC3 in the eWAT without altering the expression of AMPK, compared with that in the HFD mice. In conclusion, metformin reduced the body weight and hepatic steatosis of the HFD‑induced obese mice, without altering food intake. The effects of metformin treatment may be attributable to the improved induction of hepatic autophagy and the inhibited induction of adipose tissue autophagy.

View Figures

View References

1	Ogden CL, Carroll MD, Kit BK and Flegal KM: Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 311:806–814. 2014. View Article : Google Scholar : PubMed/NCBI
2	Reed M, Cygan H, Lui K and Mullen M: Identification, prevention, and management of childhood overweight and obesity in a pediatric primary care center. Clin Pediatr (Phila). 55:860–866. 2016. View Article : Google Scholar : PubMed/NCBI
3	Deiuliis JA: MicroRNAs as regulators of metabolic disease: Pathophysiologic significance and emerging role as biomarkers and therapeutics. Int J Obes (Lond). 40:88–101. 2016. View Article : Google Scholar : PubMed/NCBI
4	Sweeting AN, Hocking SL and Markovic TP: Pharmacotherapy for the treatment of obesity. Mol Cell Endocrinol. 418:173–183. 2015. View Article : Google Scholar : PubMed/NCBI
5	Lee A and Morley JE: Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res. 6:47–53. 1998. View Article : Google Scholar : PubMed/NCBI
6	Kim HJ, Zhang XH, Park EY, Shin KH, Choi SH, Chun BG and Kim DH: Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice. Physiol Behav. 110–111:213–220. 2013. View Article : Google Scholar
7	Woo SL, Xu H, Li H, Zhao Y, Hu X, Zhao J, Guo X, Guo T, Botchlett R, Qi T, et al: Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity. PLoS One. 9:e911112014. View Article : Google Scholar : PubMed/NCBI
8	Song YM, Lee YH, Kim JW, Ham DS, Kang ES, Cha BS, Lee HC and Lee BW: Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway. Autophagy. 11:46–59. 2015. View Article : Google Scholar : PubMed/NCBI
9	Lavallard VJ and Gual P: Autophagy and non-alcoholic fatty liver disease. Biomed Res Int. 2014:1201792014. View Article : Google Scholar : PubMed/NCBI
10	Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, et al: Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 90:1383–1435. 2010. View Article : Google Scholar : PubMed/NCBI
11	Lee JW, Park S, Takahashi Y and Wang HG: The association of AMPK with ULK1 regulates autophagy. PLoS One. 5:e153942010. View Article : Google Scholar : PubMed/NCBI
12	Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM and Czaja MJ: Autophagy regulates lipid metabolism. Nature. 458:1131–1135. 2009. View Article : Google Scholar : PubMed/NCBI
13	Kovsan J, Blüher M, Tarnovscki T, Klöting N, Kirshtein B, Madar L, Shai I, Golan R, Harman-Boehm I, Schön MR, et al: Altered autophagy in human adipose tissues in obesity. J Clin Endocrinol Metab. 96:E268–E277. 2011. View Article : Google Scholar : PubMed/NCBI
14	Singh R, Xiang Y, Wang Y, Baikati K, Cuervo AM, Luu YK, Tang Y, Pessin JE, Schwartz GJ and Czaja MJ: Autophagy regulates adipose mass and differentiation in mice. J Clin Invest. 119:3329–3339. 2009.PubMed/NCBI
15	National Research Council (US) Committee for the update of the guide for the care and use of laboratory animals: Guide for the care and use of laboratory animals. 8th. Washington, DC: National Academies Press; 2011
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M and Melchionda N: Metformin in non-alcoholic steatohepatitis. Lancet. 358:893–894. 2001. View Article : Google Scholar : PubMed/NCBI
18	Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, David E, Rizzetto M and Marchesini G: A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol. 100:1082–1090. 2005. View Article : Google Scholar : PubMed/NCBI
19	Shi WY, Xiao D, Wang L, Dong LH, Yan ZX, Shen ZX, Chen SJ, Chen Y and Zhao WL: Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis. 3:e2752012. View Article : Google Scholar : PubMed/NCBI
20	Singh R and Cuervo AM: Lipophagy: Connecting autophagy and lipid metabolism. Int J Cell Biol. 2012:2820412012. View Article : Google Scholar : PubMed/NCBI
21	Song S, Andrikopoulos S, Filippis C, Thorburn AW, Khan D and Proietto J: Mechanism of fat-induced hepatic gluconeogenesis: Effect of metformin. Am J Physiol Endocrinol Metab. 281:E275–E282. 2001.PubMed/NCBI
22	Shin NR, Lee JC, Lee HY, Kim MS, Whon TW, Lee MS and Bae JW: An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 63:727–735. 2014. View Article : Google Scholar : PubMed/NCBI
23	Anthony J, Kelkar A, Wilankar C, Ranjith V, Bhumra SK, Mutt SJ, Deka N, Sivaramakrishnan H, Sharma S and Marita AR: Discovery of p1736, a novel antidiabetic compound that improves peripheral insulin sensitivity in mice models. PLoS One. 8:e779462013. View Article : Google Scholar : PubMed/NCBI